Wednesday, October 25, 2006 12:00:00 AM PDT | VentureDeal Staff
KALAMAZOO, MI --ProNAi announced today that it has closed a funding round totaling $6.65 million. The round included investments from the Michigan Economic Development Corp, Apjohn Ventures, Amherst Fund, Grand Angels and Sigvion Ventures.The company plans to use the funding to continue development of its leading drug candidate, PNT-100, which is a new class of nucleic-aced drugs based on DNA interference. They expect to submit the new candidate to the FDA in 2007.ProNAi was founded in 2004 and has received $11 million to date.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
Email Sign Up
© 2016 VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.